Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is the new case of the Monkeypox virus worth concerning?

New bioluminescent tool to quantify disease resistance in plants

Do lncRNA MCM3AP-AS1 develop lung cancer?

Is the new case of the Monkeypox virus worth concerning?
  • BiotechToday
  • World

Is the new case of the Monkeypox virus worth concerning?

BioTech Today July 20, 2021July 19, 2021

Aqsa, Jamia Millia Islamia

Years after the 2003 United States outbreak of the Monkeypox virus, a new case has been reported recently. The infected person is a Texas resident who recently traveled from Africa. This patient took two flights during their return from Africa to the U.S. in early July, according to a CDC (Centre for Disease Control and Prevention) press release: one from Lagos, Nigeria, to Atlanta, and one from Atlanta to Dallas. The patient developed a rash in Nigeria, but it worsened after the person returned to Dallas. When he went to the hospital, he developed characteristic symptoms like rashes on his face and elsewhere on the body.

CDC with Delta Air Lines and state and local health officials are now working to contact passengers who may have been in contact with the patient during two flights.

What is the Monkeypox Virus?

Monkeypox virus is a double-stranded DNA virus. It belongs to the genus Orthopoxvirus. It is very similar to smallpox but is less infectious and causes lower deaths when compared to it. Monkey virus is a rare but serious viral illness that occurs mainly in the rainforest countries of Central and West Africa. The causative agent is the monkeypox virus. The infection may last for 2-4 weeks.

How does the Monkeypox virus Spread:

The Monkeypox virus is very similar to smallpox but is less infectious when compared to it. It can spread to humans from an infected animal when scratched or bitten by it or direct contact with the animal’s lesions or body fluids. It can also spread from person to person through large droplets. In addition, it may spread by direct contact with the body fluids of an infected person or with virus-contaminated objects, such as bedding or clothing. It was first identified as laboratory monkeys in 1958. The virus was also isolated from an African tree squirrel, which may be the natural host. Monkeypox also could infect mice, rats, and rabbits. In 1970, the first human case was reported.

Symptoms:

The symptoms include:-

  • Enlargement of lymph nodes
  • Fever
  • Headache
  • muscle aches
  • backache
  • A feeling of discomfort and exhaustion
  •  the patient develops a papular rash after a fever
Some previous outbreaks of the disease::
  1. 2003 U.S. Outbreak – This outbreak took place in the year 2003 with 47 confirmed cases. The cause of this outbreak was identified as a shipment of animals from Ghana to Texas. This shipment introduced the monkeypox virus from West African to the United States. The people who purchased these animals as pets became infected with the monkeypox virus. Patients were reported to have symptoms like – fever, headache, muscle aches, and rash. The vaccine against the virus was the smallpox vaccine.
  2. 2017-19 Nigeria Outbreak – Monkeypox spread around the southeast and southern Nigeria during 2017-19. This outbreak spread across multiple states of Nigeria.
  3. 2018 – U.K. cases – In September 2018, the first case of the monkeypox virus was recorded. The infected person was a Nigerian national who got the infection from Nigeria before traveling to the United Kingdom. Few cases were reported later that year from the people who came in contact with the Nigerian national.
  4. 2019 Singapore Case – The country’s first case came on 8 May 2019. The patient was a 38-year-old man who traveled from Nigeria and was hospitalized in Singapore. As a result, 22 people who came in contact with the infected person were quarantined.

Also read: New bioluminescent tool to quantify disease resistance in plants

References:
  • “Texas Resident Hospitalized with Rare Monkeypox Diagnosis 18 Years after Outbreak in US.” USA TODAY, https://www.usatoday.com/story/news/health/2021/07/16/first-u-s-case-of-human-monkeypox-18-years-found-in-texan/7998388002/
  • 2003 United States Outbreak of Monkeypox | Monkeypox | Poxvirus | CDC. 19 Dec. 2018, https://www.cdc.gov/poxvirus/monkeypox/outbreak.html
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged DNA virus illness infection Monkeypox Monkeypox virus outbreak smallpox Texas transmission virus

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Do lncRNA MCM3AP-AS1 develop lung cancer?

bioxone July 20, 2021

Monika Raman, PSG College of Technology, Coimbatore Lung cancer, one of the most common and deadliest cancers, affected 2.2 million people and caused 1.79 million deaths worldwide in 2020. Most of the primary lung cancers are carcinomas. Small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) are their two main types.  About 15% of lung […]

MCM3AP-AS1

Related Post

  • BiotechToday
  • World

Meningitis- creating bacteria: Weapons to destroy our immune system

bioxone May 12, 2021May 11, 2021

Ayooshi Mitra, Amity University Kolkata Meningitis is an inflammatory condition that affects the membranes that surround the brain and spinal cord. Viruses, bacteria, fungi, and parasites can all cause it. Bacterial meningitis is one of the most serious types, and it is a leading cause of death and disability in children all over the world. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Pig-to-human heart transplantation: A solution to the rarity of donor organs

bioxone October 10, 2020October 10, 2020

Sayak Banerjee, Amity University Kolkata Many a time, a heart transplant is the only hope of survival for patients with any cardiac problems when every other surgery fails. For this, they have to wait for too long. Cardiac xenotransplantation has been a target of scientists globally for years, and in one year, pig hearts might […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 vaccine in Immunocompromised individuals.

bioxone July 10, 2021July 9, 2021

Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy